BPCR BioPharma Credit PLC
0.9680USD-1.22%Mkt Cap: 1.10B $P/E: 9.80Today
Industry Peers
Asset Management$173.79BUSDP/E 25.6
$133.67BUSDP/E 25.0
INVE-B
Investor AB (publ)$119.41BUSDP/E 4.8
INVE-A
Investor AB (publ)$117.07BUSDP/E 4.7
$82.82BUSDP/E 28.6
$85.69BUSDP/E 70.3
$82.55BUSDP/E 67.2
$73.88BUSDP/E 26.4
$71.08BUSDP/E 25.3
$68.24BUSDP/E 41.4
$47.85BUSDP/E 15.4
$43.37BUSDP/E 11.8
$38.40BUSDP/E 53.3
$33.31BUSDP/E 28.7
$30.77BUSDP/E 14.5
$30.25BUSDP/E 13.7
$26.41BUSDP/E 4.4
$24.90BUSD
$23.46BUSD
$23.28BUSDP/E 15.5
Key Statistics
Company
Market Cap1.10B USD
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)129.89M USD
Revenue/Share—
Last Price0.9680 USD
Fiscal Year End—
MR Quarter—
Employees—
CountryGB
SectorFinancial Services
IndustryAsset Management
ISINGB00BDGKMY29
Valuation
P/E (Trailing)9.80
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.96
EPS (TTM)—
EPS (Forward)—
52W Range
0.000097% of range1.000
52W High1.000 USD
52W Low0.0000 USD
Profitability
Gross Margin—
Oper. Margin—
EBITDA Margin—
Profit Margin98.36%
ROE11.29%
ROA11.12%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF91.09M USD
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio—
Quick Ratio—
Book Value/Sh1.01 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.07 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.12B
Float—
Insiders—
Institutions—
Technical
SMA 500.9721 (-0.4%)
SMA 2000.9484 (+2.1%)
Beta—
S&P 52W Chg—
Avg Vol (30d)1.27M
Avg Vol (10d)1.26M
Technical Indicators
RSI (14)56.1
MACD0.0032
MACD Signal0.0028
MACD Hist.+0.0004
BB Upper0.9875 USD
BB Middle0.9748 USD
BB Lower0.9621 USD
BB Width2.61%
ATR (14)0.0107 USD
Vol Ratio (20d)1.65x